Anhorn Medicines

Developer of therapeutics for cancer, neurology, and age-related diseases

placeTaipei, Taipei, Taiwan calendar_todayFounded 2020 language anhornmed.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace active. Cited 23 times.

YearFilings
20241
20251

Social engagement

Social engagement: 651 social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Taiwania Capital.

Investor typeCountShare
Venture capital233%
Other / undisclosed467%

Recent activity

2 Jul 2026
Expansion
Kansai City Government Department of Economic Development
23 Jun 2026
Milestone
regulatory
12 Feb 2026
Event
Targeted Therapies Partnering & Licensing Summit Asia
Coming soon